Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+30.0%
5Y CAGR+38.5%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+30.0%/yr
vs +38.5%/yr prior
5Y CAGR
+38.5%/yr
Recent deceleration
Acceleration
-8.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.14B | +33.7% |
| 2024 | $855.91M | +34.4% |
| 2023 | $636.89M | +22.3% |
| 2022 | $520.81M | +43.9% |
| 2021 | $361.90M | +61.4% |
| 2020 | $224.23M | +49.0% |
| 2019 | $150.45M | +6.2% |
| 2018 | $141.73M | -50.4% |
| 2017 | $285.46M | +151.5% |
| 2016 | $113.48M | - |